Illumina Inc ILMN

Technology Scientific & Technical Instruments

Illumina, Inc. is engaged in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. It is also a developer of an emerging and highly differentiated single-cell technology.

NDAQ:ILMN - Post by User

Illumina Inc

Bullboard Posts

Post by R_J_on Jul 01, 2020 7:09am

235 Views

Post# 31211514

End of First Half - 2020

End of the First Half Report for 2020 for Illumina Inc.
-
ILMN closed on 06/30/2020 at US$ 370.35
ILMN closed on 12/31/2019 at US$ 331.74
-
This is a 11.6% gain, a US$ 38.61 gain, for the first half of 2020.
-
S&P 500 Index for first half of 2020.
Closed on 2020/06/30 @ 3100.2
Closed on 2019/12/31 @ 3230.7
This is a loss for the 1st Half of 4.0%, or 130.4
Its MA(200) ended the 1st Half @ 3021.6
-
Two Hundred Day Moving Average [MA(200)] stuff.
ILMN's MA(200) ended June at US$309.63
ILMN is now 19.6% above its MA(200).
-
Who is in charge?
Francis A. DeSouza, CEO
-
RJ

Bullboard Posts

Three business reasons companies need to recycle e-waste